Worried about the impact of GLP-1 shortages on your employees? Calibrate has shown that medication is a tool—not the entire treatment. Our comprehensive lifestyle intervention empowers members to achieve sustainable weight loss—with or without continuous medication, and we have the data to back it up. Calibrate recently conducted a real-world analysis of medication access and clinical outcomes for obesity treatment with GLP-1s. This analysis, presented at the Endocrine Society, reveals that even with significant gaps in medication access, Calibrate members achieved clinically significant weight loss outcomes. Key Findings: - Members who did not experience a 13-week medication disruption over 24 months achieved an average weight loss of 17.28% at their 12-month mark. - Members who experienced a medication disruption of at least 13 weeks over the same period still saw an impressive average weight loss of 14.96% Whether on a GLP-1 or not, Calibrate members lose weight—and keep it off, for good. To read more about our findings, check out our poster: https://lnkd.in/eC_wHCCW #HolisticApproach #GLP1s #ClinicalOutcomes
Calibrate’s Post
More Relevant Posts
-
Medical weight loss refers to a structured weight management program that is supervised by medical professionals, typically including physicians and other healthcare providers. It focuses on achieving weight loss and improving overall health through evidence-based strategies and interventions. These programs are tailored to individual needs and often involve a comprehensive approach that combines diet, physical activity, behavior modification, and medication or other medical interventions. They are designed to address underlying factors contributing to weight gain or difficulty losing weight, such as hormonal imbalances, metabolic disorders, or certain medical conditions. https://lnkd.in/eqiesDdB #ApexHormoneHealth #HormoneReplacement #TestosteroneReplacement
To view or add a comment, sign in
-
⚖️Understanding weight loss with weight loss medications! 💊When people suffering from #obesity use a medicine called tirzepatide, they can lose a lot of weight, but e new study shows something important for these people! Those who kept taking tirzepatide for more than a year continued to lose weight, but, those who stopped taking it and switched to a fake pill (placebo) started to gain weight back again! 🔬For the professionals out there: Among adults with obesity who had previously lost weight (21 percent mean weight reduction) during a 36-week, open-label trial of tirzepatide, those randomly assigned to continue tirzepatide for 52 weeks experienced additional weight loss, whereas those assigned to placebo partially regained (-5.5 versus +14 percent mean weight change, respectively) 🚨This study tells us that to keep weight off with drugs, it might be necessary to takethem for a long time, which is something unsustainable and not so economic and healthy probably! 📖Read original study: https://lnkd.in/eYrSU58j #WeightLoss #Tirzepatide #StayHealthy
To view or add a comment, sign in
-
Join us at #mdapaconference2024: Wed, Sept 25 7:30-8:30 am Obesity and Weight loss with GLP-1’s - Matthew Kearney, MS, MPAS, PA-C 1.Conference participants will understand which GLP medications will aid in weight loss. 2. Conference participants will be able to explain to patient’s how these medications work in the body to cause weight loss. 3. Conference participants will be able to explain potential benefits of GLP-1 medications. 4. Conference participants will be able to explain potential side effects of GLP-1 medications.
To view or add a comment, sign in
-
With obesity affecting 40% of adults over age 20, the demand for effective treatments has never been more urgent. Our industry expert, Russ Cerny cuts through the noise, shedding light on GLP-1s and their pivotal role in weight management. Join us at ProCare Rx as we delve into the revolutionary impact of GLP-1 medications, shaping the future of weight management and healthcare benefits. Stay ahead of the curve and discover how these treatments are transforming the landscape. Let's navigate the future of healthcare together! https://hubs.ly/Q02KQp0V0 #PharmacyBenefits #HealthcareSolutions #WeightManagement #GLP1
To view or add a comment, sign in
-
Active B12 Test Market size was valued at USD 182.23 Mn. in 2023 and the Active B12 Test revenue is expected to grow at a CAGR of 24.7% from 2024 to 2030, reaching nearly USD 854.45 Mn. by 2030. The Active B12 Test Market is witnessing remarkable growth as awareness of the importance of vitamin B12 in overall health rises. Active B12 tests offer accurate detection of B12 deficiency, which is crucial for preventing serious health issues such as anemia, neuropathy, and cognitive impairments. With advancements in diagnostic technology, healthcare providers can now offer more precise and timely interventions. Stay informed about the latest trends and innovations in this vital sector. Request for sample Request:https://lnkd.in/d9nsWJkA #ActiveB12Test #HealthcareInnovation #DiagnosticTesting #VitaminB12 #HealthAndWellness #MedicalAdvancements
To view or add a comment, sign in
-
Modern Perspectives on Obesity Treatment with Professor Carel Le Roux In a revealing interview, Professor Carel Le Roux, an expert in metabolic medicine, discusses how modern treatments for obesity have transformed patient outcomes. He emphasizes the need to view obesity as a complex disease rather than a simple lifestyle issue. With new medical therapies and comprehensive care plans, patients can experience better results in managing their weight, leading to long-term health improvements. #ObesityTreatment #MetabolicMedicine #ObesityCare #PatientOutcomes #MedicalTherapies #HealthcareTransformation Credits: @Professor Carel Le Roux
To view or add a comment, sign in
-
ECFMG Certified| Admin of Amedcure | Medical Officer | Primary Care Physician | Continuous Learner | Proficient in AI, Microsoft Office, SPSS, R, Notion, Canva, Graphics, Video Editing, Python and Web Development
Excited to explore the intricate details of weight management goals in pharmacological therapy for individuals with diabetes! These goals are vital for achieving lasting weight loss, enhancing insulin sensitivity, and improving overall health. Choosing the right pharmacological agent in clinical settings demands a patient-centered approach, taking into account factors like comorbidities, medication history, and patient preferences. Eager to apply these insights to enhance diabetes management outcomes! #DiabetesManagement #WeightLossGoals #PatientCenteredCare
To view or add a comment, sign in
-
The "Practical Strategies for Applying Evidence and Patient Perspectives to Improve Obesity Management" program, brought to you by Clinical Care Options and supported by Eli Lilly and Company provides education on how to enhance obesity treatment, minimize complications, personalize care plans, and support long-term weight loss success. Discover more at https://bit.ly/3RtDVdW. #Obesity #ObesityTreatment #ObesityManagement
To view or add a comment, sign in
-
2024 Northern Virginia Top Doc | 2023 -2021 Washingtonian Top Doc | 2021 Arlington Top Doc | CEO, NVFP
In the battle against #obesity, physicians play a crucial role in guiding patients towards a healthier and more sustainable lifestyle. While healthy eating and physical activity remain fundamental pillars in weight management, there are instances when additional support becomes necessary. Enter anti-obesity medications — FDA-approved medications to help people achieve and sustain a healthier weight. But, the world of anti-obesity medications is complex, and these new and emerging tools are often misunderstood. Learn more from Sara Berg, MS's informational article. #NVFP #conciergemedicine https://lnkd.in/eScsXcb5
To view or add a comment, sign in
-
In a world where traditional healthcare often falls short in addressing the diverse and individualized needs of patients and where the use of GLP-1 medications is widespread and unguided, it's crucial to acknowledge that it is not a one-size-fits-all approach. Using these medications without proper guidance and follow-up can lead to suboptimal results. Zone.Health's offers evidence-based solutions that overcome the limitations of traditional healthcare. Today, we're thrilled to share the first clinical outcome report from Zone.Health, and the results are nothing short of extraordinary: - 8% weight loss at the 3 months mark - 13% weight loss at the 6 months mark - 20% weight loss at the 9 months mark - 95% of members improved at least two metabolic markers (improved lipid profile, improved liver health and significant reductions in Fat Mass. Impressively, 79% of prediabetes cases reversed their HbA1c back to normal (avg. HbA1c of 5.39) and improved their metabolic profile within only 3 months. At the 26-week mark, Zone.Health's outcomes surpassed published STEP-4, RCTs, and RWE results using similar medications. Attaching the full report for your reference, let me know what do you think about these results. Does digital health play an important role in advanced therapy for obesity management? Zone.Health Ihsan Almarzooqi Ali Hashemi Zeina A. #glp1 #digitalhealth #ZoneHealth #lifestylechanges
To view or add a comment, sign in
58,129 followers